Pal Miheller, Ph.D.
Affiliations: | 2007 | Semmelweis Egyetem, Hungary |
Area:
PathologyGoogle:
"Pal Miheller"Parents
Sign in to add mentorLaszlo Herszenyi | grad student | 2007 | Semmelweis Egyetem | |
(Csontanyagcsere valtozasok kortani hattere gyulladasos belbetegsegben.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Sánta A, Szántó KJ, Sarlós P, et al. (2020) Letter: suicide risk among adult inflammatory bowel disease patients. Alimentary Pharmacology & Therapeutics. 51: 1213-1214 |
Molnár T, Miheller P, Sarlós P, et al. (2020) P817 Influence of inflammatory bowel diseases on depression and suicidal risk: a questionnaire-based survey Journal of Crohns & Colitis. 14 |
Bor R, Fábián A, Matuz M, et al. (2019) Real-life efficacy of vedolizumab on endoscopic healing in inflammatory bowel disease- A nationwide Hungarian cohort study. Expert Opinion On Biological Therapy |
Bálint A, Rutka M, Kolar M, et al. (2018) Infliximab biosimilar CT-P13 therapy is effective in maintaining endoscopic remission in ulcerative colitis - results from multicentre observational cohort. Expert Opinion On Biological Therapy |
Bor R, Klaudia F, Miheller P, et al. (2018) DOP007 Efficacy of vedolizumab induction therapy on clinical and endoscopic activity in patients with anti-tumour necrosis factor alpha-resistant inflammatory bowel disease Journal of Crohns & Colitis. 12 |
Gonczi L, Gecse KB, Vegh Z, et al. (2017) Long-term Efficacy, Safety, and Immunogenicity of Biosimilar Infliximab After One Year in a Prospective Nationwide Cohort. Inflammatory Bowel Diseases |
Bálint A, Rutka M, Végh Z, et al. (2017) Frequency and Characteristics of Infusion Reactions during Biosimilar Infliximab Treatment in Inflammatory Bowel Diseases: results from Central European nationwide cohort. Expert Opinion On Drug Safety |
Molnár A, Csontos ÁA, Dakó S, et al. (2017) [Investigating the efficacy of nutrition therapy for outpatients with inflammatory bowel disease]. Orvosi Hetilap. 158: 731-739 |
Milassin Á, Rutka M, Csontos ÁA, et al. (2017) What Is the Personal Experience of IBD Patients about Their Anti-TNF-Alpha Therapy? Health. 9: 1007-1018 |
Csontos ÁA, Molnár A, Piri Z, et al. (2016) Malnutrition risk questionnaire combined with body composition measurement in malnutrition screening in inflammatory bowel disease. Revista Espanola De Enfermedades Digestivas : Organo Oficial De La Sociedad Espanola De Patologia Digestiva. 109 |